Want to join the conversation?
Rupesh Parikh of Oppenheimer asks about deflation for the balance of 2016 and early part of 2017. CFO Mike Schlotman responded that $KR did not provide a point estimate or a range in its 8-K, but the company expects to see product cost deflation for the balance of the year. He added that deflation could extend into early 2017 as well.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?